“Umbilical Cord Blood Expansion with Nicotinamide Provides Long-Term Multilineage Engraftment”, J Clin Invest, vol. 124, pp. 3121-3128, 2014.
, , “Umbilical Cord Blood Transplantation in Adults: Results of the Prospective Cord Blood Transplantation (COBLT)”, Biol Blood Marrow Transplant, vol. 11, pp. 2149-2160, 2005.
, “Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT).”, Biol Blood Marrow Transplant, vol. 11, no. 2, pp. 149-60, 2005.
, “Umbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplantation Outcomes.”, Biol Blood Marrow Transplant, vol. 23, no. 10, pp. 1714-1721, 2017.
, “Umbilical Cord Blood Transplantation in Pediatric Patients with Malignant Diseases: Results of a Prospective, Multi-Institutional NHLBI Sponsored Trial”, in 2005 ASBMT Tandem BMT Meetings, Keystone, CO, 2005.
, “Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-Exposure Prophylaxis Among Men Who Have Sex With Men in Kenya”, AIDS Behav, vol. 19, pp. 794-801, 2015.
, “Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in Kenya.”, AIDS Behav, vol. 19, no. 5, pp. 794-801, 2015.
, “Understanding hospital readiness for computerized physician order entry.”, Jt Comm J Qual Saf, vol. 29, no. 7, pp. 336-44, 2003.
, “Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).”, Biol Blood Marrow Transplant, vol. 18, no. 8, pp. 1265-72, 2012.
, “Unrelated Donor Cord Blood Transplantation for Children with Severe Sickle Cell Disease: Results of One Cohort from the Phase II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)”, Biol Blood Marrow Transplant, vol. 18, pp. 1265-1272, 2012.
, “Untitled”, 2004.
, “Untitled”, 2001.
“Untitled”, 2000.
, “Update from studies in pediatric liver transplantation.”, Transplant Proc, vol. 33, no. 7-8, pp. 3604-5, 2001.
, “Updated multivariate analyses of patient characteristics as predictors of survival in hormone-refractory prostate cancer patients treated with suramin”, Cancer Epidemiology, Biomarkers & Prevention, vol. 7, pp. 631-34, 1998.
, “Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0.”, J Clin Oncol, p. JCO2003613, 2021.
, “Updates to the National Institute of Neurological Disorders and Stroke (NINDS) Cerebral Palsy Common Data Elements: Participant Condition Characteristics.”, in PUB:American Academy for Cerebral Palsy and Developmental Medicine 74th Annual Virtual Meeting, Virtual Live Conference, 2020.
, , “Updates to the National Institute of Neurological Disorders and Stroke (NINDS) Multiple Sclerosis (MS) Common Data Element (CDE) Recommendations: 2018 MS Oversight Committee (OC) Review”, in American Academy of Neurology 71st Annual Meeting, Philadelphia, PA, 2019.
, “Updates to the National Institute of Neurological Disorders and Stroke (NINDS) Spinal Cord Injury (SCI) Common Data Element Recommendations”, in International Spinal Cord Society 59th Annual Scientific Virtual Meeting, Virtual, 2020.
, “Use of a prescription opioid registry to examine opioid misuse and overdose in an integrated health system.”, Prev Med, vol. 110, pp. 31-37, 2018.
, “Use of biological assignment in hematopoietic stem cell transplantation clinical trials.”, Clin Trials, vol. 5, no. 6, pp. 607-16, 2008.
, “Use of Biological Assignment in Hematopoietic Stem Cell Transplantation Clinical Trials”, Clin Trials, vol. 5, pp. 607-616, 2008.
, “Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-bli”, Lancet Infect Dis, vol. 16, no. 1, pp. 31-42, 2016.
,